Largest pharmaceuticals by market cap
Eli Lilly leads the 14 pharmaceuticals ranked by market value, at AED 4.63T, ahead of Johnson & Johnson (AED 2.48T) and AbbVie (AED 1.91T). Figures as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 14
- First
- Eli LillyAED 4.63T
- Median
- AED 666.9B
- Combined market value
- AED 16.52T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Market cap ↓ | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|
| 1 | Eli LillyLLY · Health Care | AED 4.63T | AED 5,202.86 | 1.05% down | 39% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | AED 2.48T | AED 1,031.18 | 0.63% down | 41% up | ||
| 3 | AbbVieABBV · Health Care | AED 1.91T | AED 1,078.76 | 0.28% down | 26% up | ||
| 4 | Merck & CoMRK · Health Care | AED 1.3T | AED 529.27 | 0.24% down | 50% up | ||
| 5 | NovartisNVS · Health Care | AED 1.11T | AED 587.39 | 0.17% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | AED 1.04T | AED 673.39 | 0.36% down | 3% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | AED 675.5B | AED 390.04 | 1.16% down | 17% down | ||
| 8 | Novo NordiskNVO · Health Care | AED 658.2B | AED 149.35 | 2.25% down | 13% down | ||
| 9 | PfizerPFE · Health Care | AED 598.1B | AED 104.93 | 1.00% down | 13% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | AED 497.4B | AED 1,961.77 | 0.68% down | 23% up | ||
| 11 | Bristol-Myers SquibbBMY · Health Care | AED 457.9B | AED 224.03 | 3.07% down | 34% up | ||
| 12 | SanofiSNY · Health Care | AED 422.8B | AED 176.07 | 0.93% down | 4% down | ||
| 13 | Regeneron PharmaceuticalsREGN · Health Care | AED 365.7B | AED 3,534.97 | 1.06% up | 31% up | ||
| 14 | GSKGSK · Health Care | AED 364.3B | AED 181.73 | 1.84% down | 6% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED).
Questions and answers
Which pharmaceuticals rank first by market value?
Eli Lilly (AED 4.63T), Johnson & Johnson (AED 2.48T) and AbbVie (AED 1.91T) are the top three of the 14 pharmaceuticals ranked by market value as of 17 Nov 2026, 17:16 UTC.
How many pharmaceuticals are in this ranking?
14 are ranked by market value.
What are these pharmaceuticals worth together?
Their combined market value is AED 16.52T as of 17 Nov 2026, 17:16 UTC.
What does ranking by market value measure?
What the stock market values the whole company at: its share price times the number of its shares.
Learn how this ranking works
All markets guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by market cap”, data as of 17 November 2026. https://funkfolio.com/companies/category/pharmaceuticals
Underlying data: Yahoo Finance; SEC EDGAR.